2CS-CHX T Operon Signature of Chlorhexidine Tolerance among Enterococcus faecium Isolates
Author(s) -
Bárbara Duarte,
Ana P. Pereira,
Ana R. Freitas,
Teresa M. Coque,
Anette M. Hammerum,
Henrik Hasman,
Patrı́cia Antunes,
Luı́sa Peixe,
Carla Novais
Publication year - 2019
Publication title -
applied and environmental microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.552
H-Index - 324
eISSN - 1070-6291
pISSN - 0099-2240
DOI - 10.1128/aem.01589-19
Subject(s) - enterococcus faecium , operon , microbiology and biotechnology , biology , clade , genetics , gene , escherichia coli , antibiotics , phylogenetics
Chlorhexidine is one of the substances included in the World Health Organization’s list of essential medicines, which comprises the safest and most effective medicines needed in global health systems. Although it has been widely applied as a disinfectant and antiseptic in health care (skin, hands, mouthwashes, eye drops) since the 1950s, its use in hospitals to prevent nosocomial infections has increased worldwide in recent years. Here, we provide a comprehensive study on chlorhexidine tolerance among strains ofEnterococcus faecium , one of the leading nosocomial agents worldwide, and identify a novel 2CS-CHXT operon as a signature of tolerant strains occurring in diverse phylogenomic groups. Our data allowed for the proposal of a tentative epidemiological cutoff of 8 mg/liter, which is useful to detect tolerantE. faecium populations in surveillance studies in community and clinical contexts. The prediction of 2CS-CHXT regulons will also facilitate the design of future experimental studies to better uncover chlorhexidine tolerance amongE. faecium bacteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom